Facultad
FACULTAD DE CIENCIAS BIOMÉDICAS Y DE LA SALUD
Capítulos de Libro (12) Publicaciones en las que ha participado algún/a investigador/a
2006
-
Action of selective estrogen receptor modulators (SERMs) through the classical mechanism of estrogen action
Selective Estrogen Receptor Modulators: A New Brand of Multitarget Drugs (Springer Berlin Heidelberg), pp. 71-77
-
Clinical pharmacology of selective estrogen receptor modulators (SERMs)
Selective Estrogen Receptor Modulators: A New Brand of Multitarget Drugs (Springer Berlin Heidelberg), pp. 49-69
-
Desarrollo personal
Atención a las personas mayores: intervención práctica (Universitas), pp. 125-158
-
Fluoroscopic and Angiographic Heart Anatomy for Catheter Mapping and Ablation of Arrhythmias
Catheter Ablation of Cardiac Arrhythmias (Elsevier Inc.), pp. 85-106
-
Insulin-like Growth Factor-I and Neuroprotection
The Somatotrophic Axis in Brain Function (Elsevier Inc.), pp. 209-215
-
Investigar sobre la enfermedad de alzheimer: nuevas teorías
Alzheimer: un reto de presente y futuro (Asociación Familiares Enfermos Alzheimer A Coruña (AFACO)), pp. 162-169
-
Nutrition on match day
Nutrition and Football: The FIFA/FMARC Consensus on Sports Nutrition (Routledge Taylor & Francis Group), pp. 38-55
-
Sepsis
Clinical Critical Care Medicine (Elsevier), pp. 589-602
-
TDZD's: Selective and ATP Noncompetitive Glycogen Synthase Kinase 3 Inhibitors
Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors: Drug Discovery and Development (John Wiley and Sons Inc.), pp. 257-280
-
TDZD's: Selective and ATP Noncompetitive Glycogen Synthase Kinase 3 Inhibitors
Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors: Drug Discovery and Development (John Wiley & Sons, Inc.), pp. 257-280
-
Targeting the HER family of receptors in the treatment of advanced breast cancer
Breast Cancer and Molecular Medicine (Springer Berlin Heidelberg), pp. 643-670
-
The hypothalamus-pituitary-ovarian axis as a model system for the study of SERM effects: An overview of experimental and clinical studies
Selective Estrogen Receptor Modulators: A New Brand of Multitarget Drugs (Springer Berlin Heidelberg), pp. 103-139